Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Iterum Therapeutics plc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 41 | 39 | −2 |
| Shares | 5.10M | 5.89M | +786.9K (+15.4%) |
| Value | $1.80M | $1.18M | −$628.4K (−34.8%) |
New holders (7)
Institutions that held Iterum Therapeutics plc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 304,684 | $61.0K | 0.00% |
| Gsa Capital Partners LLP | 304,684 | $61.0K | 0.01% |
| Krilogy Financial LLC | 200,000 | $40.0K | 0.00% |
| Millennium Management LLC | 88,101 | $18.0K | 0.00% |
| Jane Street Group, LLC | 37,235 | $7.00K | 0.00% |
| Principle Wealth Partners LLC | 30,000 | $6.00K | 0.00% |
| Creative Financial Designs Inc | 8,000 | $2.00K | 0.00% |
Sold out (9)
Institutions that held Iterum Therapeutics plc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Citadel Advisors LLC | 50,515 | $18.0K |
| Susquehanna International Group, LLP | 29,292 | $10.0K |
| LPL Financial LLC | 14,000 | $5.00K |
| Sigma Planning Corp | 11,500 | $4.00K |
| Koshinski Asset Management, Inc. | 5,000 | $1.77K |
| US Bancorp | 2,000 | $1.00K |
| Northwestern Mutual Wealth Management Co | 388 | $0 |
| Bollard Group LLC | 724 | $0 |
| Bedel Financial Consulting, Inc. | 20 | $0 |